Kenanga stays cautious on Pharmaniaga, reiterates 'underperform'


KUALA LUMPUR: Kenanga Research has reiterated its cautious stand on Pharmaniaga Bhd after the pharmaceutical group announced it had inked a concession agreement with the government.

"We are positive on this latest development which is in line with our expectation that the concession is now formally signed and extended. There were scant details of the concession agreement.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , pharmaceutical , Kenanga

Next In Business News

Light at the end of the tunnel
Understanding the warrant of distress
Are convention halls still good investments?
Ringgit likely to trade cautiously between RM4.09 and RM4.11 vs US dollar next week
Strong momentum seen for Vietnam equities
Asset managers in risk-on mode
Rising DRAM prices may hit consumers
Asia-Pacific ratings hold firm
HK’s lure for key IPO investors
Fewer stocks spur IPO hunt

Others Also Read